Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GlobalOne Healthcare Holding (GHH) is the healthcare investment arm of Yas Holding, an Abu Dhabi-based investment group. The company operates an integrated healthcare platform that spans the entire value chain, including pharmaceutical manufacturing, medical distribution, and biotechnology innovation. GHH's portfolio features prominent entities such as Al Ittihad Drug Store (IDS), WellPharma Medical Solutions, and Bioventure, which focuses on the commercialization of biosimilars and advanced therapeutics. The group is dedicated to enhancing regional healthcare security by localizing the production of essential medicines and medical supplies in the Middle East and North Africa. Through strategic partnerships and acquisitions, GHH continues to expand its capabilities in specialized areas like plasma-derived medicines and softgel manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GlobalOne Healthcare.